|
|
Other links at Articles > Pharmacists |
| 4. |
US Approves Drug for Rare Auto-Inflammatory Disease
|
|
|
U.S. regulators have approved canakinumab (trade name Ilaris) to treat children and adults with cryopyrin-associated periodic syndrome (CAPS), a rare but potentially fatal auto-inflammatory disease. Reuters Health Information
|
|
|